ARCHIVES

NCI To Require Reports On Adverse Drug Reactions From Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 23 | June 10, 1994

Download PDF Visit The Full Archive

Related Articles

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

March 23, 1994

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

January 31, 2014

AACI Adopts Plan To Step Up Cancer Issues Involvement

January 25, 1980

ASTRO Names Officers; Lane Returns To Rice Univ.

January 5, 2001

In Brief: Duke’s Gary Lyman to Co-Direct Fred Hutch Outcomes Research

January 10, 2014

NCAB Members Urge More Action In Support Of NCI.

December 15, 2006